Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of a newly developed potent orexin-2 receptor-selective antagonist, compound 1 m, on sleep/wakefulness states in mice
Keishi Etori, Yuki Saito, Natsuko Tsujino, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

The role of orexin in motivated behaviours
Takeshi Sakurai
Nature reviews. Neuroscience (2014) Vol. 15, Iss. 11, pp. 719-731
Closed Access | Times Cited: 414
Suvorexant for the treatment of primary insomnia: A systematic review and meta-analysis
Akira Kuriyama, Hiromitsu Tabata
Sleep Medicine Reviews (2016) Vol. 35, pp. 1-7
Closed Access | Times Cited: 133
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
An Update on Dual Orexin Receptor Antagonists and Their Potential Role in Insomnia Therapeutics
Kayla Janto, J. Roxanne Prichard, Snigdha Pusalavidyasagar
Journal of Clinical Sleep Medicine (2018) Vol. 14, Iss. 08, pp. 1399-1408
Open Access | Times Cited: 81
Discovery of (1R,2S)-2-{[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide (E2006): A Potent and Efficacious Oral Orexin Receptor Antagonist
Yu Yoshida, Yoshimitsu Naoe, Taro Terauchi, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 11, pp. 4648-4664
Closed Access | Times Cited: 76
The roles of orexins in sleep/wake regulation
Michihiro Mieda
Neuroscience Research (2017) Vol. 118, pp. 56-65
Open Access | Times Cited: 73
Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Taro Kishi, Shinji Matsunaga, Nakao Iwata
PLoS ONE (2015) Vol. 10, Iss. 8, pp. e0136910-e0136910
Open Access | Times Cited: 72
Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia
Pascal Bonaventure, Jonathan Shelton, Sujin Yun, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 354, Iss. 3, pp. 471-482
Open Access | Times Cited: 71
Suvorexant: The first orexin receptor antagonist to treat insomnia
Ashok Kumar Dubey, Shailendra Handu, Pramod Kumari Mediratta
Journal of Pharmacology and Pharmacotherapeutics (2015) Vol. 6, Iss. 2, pp. 118-121
Open Access | Times Cited: 64
Soporific effect of modified Suanzaoren Decoction on mice models of insomnia by regulating Orexin-A and HPA axis homeostasis
Yingjie Dong, Ning-Hua Jiang, Lianghui Zhan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112141-112141
Open Access | Times Cited: 55
Suvorexant ameliorates cognitive impairments and pathology in APP/PS1 transgenic mice
Fang Zhou, Xudong Yan, Chun Wang, et al.
Neurobiology of Aging (2020) Vol. 91, pp. 66-75
Closed Access | Times Cited: 50
Hypocretin/Orexin Receptor Pharmacology and Sleep Phases
Yu Sun, Ryan K. Tisdale, Thomas S. Kilduff
Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences (2021), pp. 22-37
Open Access | Times Cited: 42
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
Miles D. Thompson, Henri Xhaard, Takeshi Sakurai, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 61
Therapeutics development for addiction: Orexin-1 receptor antagonists
David A. Perrey, Yanan Zhang
Brain Research (2018) Vol. 1731, pp. 145922-145922
Open Access | Times Cited: 55
Transcranial low-level infrared laser irradiation ameliorates depression induced by reserpine in rats
Haitham S. Mohammed
Lasers in Medical Science (2016) Vol. 31, Iss. 8, pp. 1651-1656
Closed Access | Times Cited: 50
Breaking up prolonged sitting with moderate-intensity walking improves attention and executive function in Qatari females
Bryna Chrismas, Lee Taylor, Anissa Cherif, et al.
PLoS ONE (2019) Vol. 14, Iss. 7, pp. e0219565-e0219565
Open Access | Times Cited: 44
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer’s disease and Parkinson’s disease: Therapeutic avenue of Dual OXR Antagonist (DORA)
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
Profile of suvorexant in the management of insomnia
Eliza L. Sutton
Drug Design Development and Therapy (2015), pp. 6035-6035
Open Access | Times Cited: 36
Orexin OX2 Receptor Antagonists as Sleep Aids
Laura H. Jacobson, Sui Chen, Sanjida Mir, et al.
Current topics in behavioral neurosciences (2016), pp. 105-136
Open Access | Times Cited: 35
Orexin-A facilitates emergence of the rat from isoflurane anesthesia via mediation of the basal forebrain
Lina Zhang, Cen Yang, Pengrong Ouyang, et al.
Neuropeptides (2016) Vol. 58, pp. 7-14
Closed Access | Times Cited: 34
Sleep Control, GPCRs, and Glucose Metabolism
Hiroshi Tsuneki, Toshiyasu Sasaoka, Takeshi Sakurai
Trends in Endocrinology and Metabolism (2016) Vol. 27, Iss. 9, pp. 633-642
Closed Access | Times Cited: 32
Optical probing of orexin/hypocretin receptor antagonists
Shi‐Bin Li, Natalie Nevárez, William J. Giardino, et al.
SLEEP (2018) Vol. 41, Iss. 10
Open Access | Times Cited: 32
Physiological Role of Orexin/Hypocretin in the Human Body in Motivated Behavior: A Comprehensive Review
Rahul Singh, Dalia Biswas
Cureus (2023)
Open Access | Times Cited: 9
Timed Inhibition of Orexin System by Suvorexant Improved Sleep and Glucose Metabolism in Type 2 Diabetic db/db Mice
Hiroshi Tsuneki, Kanta Kon, Hisakatsu Ito, et al.
Endocrinology (2016) Vol. 157, Iss. 11, pp. 4146-4157
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top